Critical Path Institute is offering an exciting new opportunity for 
pharmacometricians. A new consortium focusing on quantitative drug development 
platforms for Huntington's disease is looking for a talented modeling and 
simulation scientist. This represents a great opportunity for intellectual and 
personal growth with a positive impact on public health, in a collaborative 
effort that allows the opportunity to interact with leading academics, industry 
scientists, and regulators. For more information, please check 
https://c-path.org/wp-content/uploads/2016/09/AssociateProgramDirectorQuantitativeMedicine.pdf
 or contact h...@c-path.org.

--Daniela J Conrado, MS PhDAssociate Director, Quantitative MedicineCritical 
Path Institute

Reply via email to